CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	12 Months Ended		56 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (2,363,344)	$ (2,081,500)	$ (9,548,746)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	211,709	197,268	791,463
Technology impairment	345,000		345,000
Common stock issued for services			300,000
Stock options and warrants	382,918	477,356	2,950,368
(Increase) decrease in assets
Grants receivable	244,479	(244,479)
Prepaid drug product for testing	(64,600)	520,040	(153,000)
Other current assets	24,554	1,304	(48,439)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	69,373	(18,145)	316,131
Net cash used in operating activities	(1,149,911)	(1,148,156)	(5,047,223)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of exclusive license - related party	(170,056)	(229,655)	(859,710)
Net cash used in investing activities	(170,056)	(229,655)	(859,710)
CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from convertible notes			435,000
Cash repayment of convertible notes			(15,000)
Net proceeds from sale of common stock	2,033,654	1,049,127	6,439,185
Net cash from financing activities	2,033,654	1,049,127	6,859,185
NET INCREASE (DECREASE) IN CASH	713,687	(328,684)	952,252
Cash, beginning of period	238,565	567,249
Cash, end of period	952,252	238,565	952,252
Cash paid for
Interest		44	445
Income taxes
Non-cash financing activities
Common stock issued upon conversion of convertible notes			420,000
Placement Agent
Non-cash financing activities
Common stock issued	179,421	117,300	591,566
MD Anderson for License
Non-cash financing activities
Common stock issued			2,354,167
Lincoln Park Capital Fund, LLC
Non-cash financing activities
Common stock issued	$ 1,549	$ 207,456	$ 209,005